Guangdong Provincial Institute of Precision Medicine Application Society to Wuhan Industrial Innovation and Development Research Institute for investigation

On August 24-25, 2022, under the leadership of the Executive Vice President and Secretary-General Sun Binggang, the Guangdong Provincial Society of Precision Medicine, went to Wuhan Industrial Innovation and Development Research Institute to investigate the innovative development mechanism of biomedical, and strengthened the cooperation of Guangdong and Hubei, and jointly. Promoting scientific and technological innovation and the transformation of scientific and technological achievements, in -depth exchanges to promote the effective docking of scientific and technological supply and the effective docking of industrial needs, and conduct docking negotiations on the specific transformation projects of the technological achievements of Wuhan.

Li Xiling (left), Dean of Wuhan Industrial Innovation and Development Research Institute

Sun Binggang (right), Executive Vice President and Secretary -General of the Guangdong Precision Medicine Society

Dean Li Xiling of Wuhan Industrial Innovation and Development Research Institute attended the investigation symposium. According to her, Wuchuang House is a new type of R & D institution founded by the People's Government of Wuhan City. The dean of the Wuchuang Academy implements the director of the director under the leadership of the council has adopted enterprise management and market -oriented operations. Do not do it, the market is unwilling to do, and the company wants to do it but cannot do it, but scientific and technological innovation must be done. " At present, Wuchuangyuan is focusing on creating a group of high -level scientific and technological service platforms, corporate innovation centers, small test platforms, intellectual property platforms, etc., continuing to help the transformation of scientific and technological achievements and industrial incubation.

Sun Binggang said that the Greater Bay Area has a strong research and development atmosphere and rich results, while the unique flexible structure and rich R & D resources of Wutuangyuan can provide strong support for industrial innovation and achievements in the field of precision medicine in the Greater Bay Area. In the future, both parties can innovate in innovation In -depth exchanges between the center and achievement transformation service platform, and deepen their cooperation between the two places in innovative technology transformation.

State Outstanding Youth Science Fund winner, Researcher Chen Jiekai, Guangzhou Institute of Biomedicine and Health of the Chinese Academy of Sciences, Professor Zhang Yuxia of the National Outstanding Youth Science Fund, the Institute of Pediatrics of the Institute of Pediatrics of the Guangzhou Women's and Children's Medical Center, Zhang Weiwei, Secretary of the Party Committee and Chairman of Foshan Medical Group, Zhang Lu, deputy secretary -general of the Guangdong Precision Medicine Society, and Dr. Yang Jianfeng Yang Jianfeng, the technical director of the Society's project department, participated in the investigation.

With the assistance of the Wounding Institute, the research team went to Wuhan Precision Medical Industry Base, Wuhan Aipotac Biotechnology Co., Ltd. (ABCLONAL), Yuanda Pharmaceutical Optics Valley R & D Center and Panjochi Entering Industry and Research Platform, and Optics Valley Biological City Achievement Exhibition The trading hall, Wuhan national human genetic resource bank, Wuhan national biological industry base, etc. conducted on -site investigations and discussions, conducted in -depth investigations on the policy, practice and achievements of the Wuhan's innovation and transformation of biomedical medicine, and promoted close cooperation between Guangdong and Hubei. The promotion of the transformation of scientific and technological achievements laid the foundation.

ABCLONAL investigation

Wu Zhicai, general manager of Ebark, introduced that Abclonal's core technology fields include automated solutions for immune products such as scientific research antibodies, molecular enzymes, CRO services and related equipment platforms, which are mainly concentrated in the upstream and midstream fields of the precision medical industry chain. In the future, it will gradually become the core supplier of global antibodies and molecular enzyme reagents, promoting seamless docking in all aspects of the industrial chain.

Yuanda Pharmaceutical Optics Valley Research and Development Center and Pan -Jie Entering Research and Research Platform for investigation

As one of the top ten R & D centers in the world's top ten R & D centers in the Yuanda Pharmaceutical Group, the Yuanda Pharmaceutical Optics Valley R & D Center and the Pan -Jie Entry Research Platform undertake the undertaking and transformation of international innovative drug research and development and technological innovation. Under the leadership of Chairman Yang Bo, the research team, he visited the laboratory of the R & D center. According to Yang Bo, the R & D center will focus on innovative drug research and development of anti -infection, tumor, ophthalmology, cardiovascular and other therapy and the development of high -end preparations, polypeptide drugs, high -end equipment, and establish strategic cooperation with scientific research institutes and medical institutions in the same area Relations, carry out pre -clinical and clinical research, and provide technical and resource guarantee for the rapid advancement of new drugs.

Optics Valley Biological City Achievement Exhibition Trading Hall Research

The Optics Valley Biological City Achievement Exhibition Trading Hall According to the industrial fields of biomedical, biomedical engineering, biomedical, precision diagnosis and treatment, smart medical care, biological services and other industries, it has fully demonstrated the innovative achievements of Optics Valley Biological City for more than ten years since its establishment. , Show the rapid development of Wuhan's biomedical industry.

Wuhan National Human Genetics Resources Library Research

The Wuhan National Human Genetics Resources Library is also known as the "Wuhan Sample Library". It was jointly constructed by Wuhan Biotechnology Research Institute and Hubei Provincial Science and Technology Investment Group and operated in November 2021. It is the first third -party sample database in China to obtain a third -party sample resource library in the country after the promulgation of the "Regulations on the Management of Human Genetics and Resources". It is also one of the third -party sample libraries that are currently approved by human genetic resources. According to reports, the current sample library has the largest automated ultra -low temperature storage equipment in the world, which can realize 15 million pipe sample storage and 30PB information storage and comprehensive data processing capabilities.

Wuhan National Biological Industry Base Research

Yu Yanfei, director of the Optics Valley Biological City Construction Financing Office and deputy director of the Wuhan National Biological Industry Base Construction Management Office, introduced that the construction of the Optics Valley Biological City was not too early in the country, but thanks to the attention and support of the provincial and municipal leaders, biology The construction and development of the city are very rapid. Through the support of the design layout and policy finance of the park, a large number of outstanding local entrepreneurship enterprises have been cultivated. At the same time, many domestic and foreign biomedical companies have settled in. At present, the biological industry has become Donghu Important engine of the economic development of high -tech zones.

- END -